BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38433486)

  • 1. Mitochondrial-Membrane-Protein-Associated Neurodegeneration in Longitudinal Magnetic Resonance Imaging Over 11 Years of Follow-Up.
    Lee J; Kim JJ; Lyoo CH; Kim YJ
    J Clin Neurol; 2024 Mar; 20(2):220-222. PubMed ID: 38433486
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
    Dusek P; Mekle R; Skowronska M; Acosta-Cabronero J; Huelnhagen T; Robinson SD; Schubert F; Deschauer M; Els A; Ittermann B; Schottmann G; Madai VI; Paul F; Klopstock T; Kmiec T; Niendorf T; Wuerfel J; Schneider SA
    Mov Disord; 2020 Jan; 35(1):142-150. PubMed ID: 31518459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye of the tiger sign in a 23 year patient with mitochondrial membrane protein associated neurodegeneration.
    Skowronska M; Kmiec T; Kurkowska-Jastrzębska I; Czlonkowska A
    J Neurol Sci; 2015 May; 352(1-2):110-1. PubMed ID: 25819119
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up.
    Murali N; Browne RW; Fellows Maxwell K; Bodziak ML; Jakimovski D; Hagemeier J; Bergsland N; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Eur J Neurol; 2020 Jan; 27(1):188-e4. PubMed ID: 31369181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial membrane protein-associated neurodegeneration (MPAN).
    Hartig M; Prokisch H; Meitinger T; Klopstock T
    Int Rev Neurobiol; 2013; 110():73-84. PubMed ID: 24209434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Eye of tiger sign" mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN).
    Yoganathan S; Sudhakar SV; Thomas M; Dutta AK; Danda S
    Brain Dev; 2016 May; 38(5):516-9. PubMed ID: 26602591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases with mitochondrial membrane protein-associated neurodegeneration: genetic features and long-term clinical follow-up.
    Mercan S; Ugur Iseri SA; Yigiter R; Akcakaya NH; Saka E; Yapici Z
    Neurocase; 2022 Feb; 28(1):37-41. PubMed ID: 35188090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pedigree analysis of C19ORF12 p.Asp18Tyr mutation in a family with mitochondrial membrane protein associated neurodegeneration].
    Li SJ; Wang LL; Qin LZ; Wang XJ; Zhang JW; Li W
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2926-2931. PubMed ID: 31607023
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging correlates of genetically characterized patients with mitochondrial disorders: A study from south India.
    Bindu PS; Arvinda H; Taly AB; Govindaraju C; Sonam K; Chiplunkar S; Kumar R; Gayathri N; Bharath Mm S; Nagappa M; Sinha S; Khan NA; Govindaraj P; Nunia V; Paramasivam A; Thangaraj K
    Mitochondrion; 2015 Nov; 25():6-16. PubMed ID: 26341968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial Sonography in Mitochondrial Membrane Protein-Associated Neurodegeneration.
    Skowronska M; Kmiec T; Czlonkowska A; Kurkowska-Jastrzębska I
    Clin Neuroradiol; 2018 Sep; 28(3):385-392. PubMed ID: 28352978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN).
    Gore E; Appleby BS; Cohen ML; DeBrosse SD; Leverenz JB; Miller BL; Siedlak SL; Zhu X; Lerner AJ
    Neurocase; 2016 Oct; 22(5):476-483. PubMed ID: 27801611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
    Lowe AJ; Rodrigues FB; Arridge M; De Vita E; Johnson EB; Scahill RI; Byrne LM; Tortelli R; Heslegrave A; Zetterberg H; Wild EJ
    Brain Commun; 2022; 4(6):fcac258. PubMed ID: 36382217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).
    Al Macki N; Al Rashdi I
    Oman Med J; 2017 Jan; 32(1):66-68. PubMed ID: 28042406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.
    Midaglia L; Rovira A; Miró B; Río J; Fissolo N; Castilló J; Sánchez A; Montalban X; Comabella M
    Eur J Neurol; 2024 Jan; 31(1):e16077. PubMed ID: 37754568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant mitochondrial membrane protein-associated neurodegeneration (MPAN) variants cluster within a specific C19orf12 isoform.
    Rickman OJ; Salter CG; Gunning AC; Fasham J; Voutsina N; Leslie JS; McGavin L; Cross HE; Posey JE; Akdemir ZC; Jhangiani SN; Lupski JR; Baple EL; Crosby AH
    Parkinsonism Relat Disord; 2021 Jan; 82():84-86. PubMed ID: 33260061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Membrane Protein-Associated Neurodegeneration.
    Yilmaz S; Gokben S; Ceylaner S
    Pediatr Neurol; 2015 Oct; 53(4):373-4. PubMed ID: 26231266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.